Back to 
Qube Research & Technologies Ltd
Qube Research & Technologies Ltd
ALGS
2 quarters
Position history for Qube Research & Technologies Ltd's holdings in Aligos Therapeutics, Inc.
No. Qube Research & Technologies exited its ALGS (Aligos Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 10,947 shares worth $94,801. Qube Research & Technologies first reported ALGS in Q3 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$94,801
Total Shares Change
-10,947
Quarter-by-Quarter History
Other major holders of ALGS: Adage Capital Partners GP, L.L.C., Woodline Partners LP, Alyeska Investment Group, L.P., Vanguard Group Inc.